$HEMP press release Feb. 7, 2014, 1:04 p.m.

New Post Public Reply Private Reply Replies (0) Message Board
GET MONEY

$HEMP press release

Feb. 7, 2014, 1:04 p.m. EST

Hemp, Inc. Signs Lucrative Consulting Contract With Resources Ventures, Inc.

LAS VEGAS, Feb 07, 2014 (GLOBE NEWSWIRE via COMTEX) -- Hemp, Inc.'s HEMP -7.27% wholly owned subsidiary, The Industrial Hemp and Medical Marijuana Consulting Company, Inc. (IHMMCC), is pleased to announce that it has signed an agreement with Resource Ventures, Inc. to provide consulting services in an effort to help guide them in their plans of expanding into the industrial hemp industry. According to the agreement, Resource Ventures, Inc. REVI +78.00% will receive professional consulting services in the Industrial Hemp/Medical Marijuana Industry, specifically in the areas of sales and marketing strategy, press releases, public company venues and overall general industry specific business guidance, on a continual basis, for the term of the agreement.

Per the agreement, Resource Ventures, Inc. will pay an initial professional consulting fee of 30 million shares of their common stock and then for each term of the Agreement (a total of 3 years) an additional 10 million shares made payable to Hemp, Inc., on a quarterly basis. "This agreement has created substantial revenue for Hemp, Inc.'s first quarter. It also creates a stable 3-year quarterly revenue, adding great value to Hemp, Inc. and its shareholders," said Bruce Perlowin, CEO of Hemp, Inc. Hemp, Inc.'s IHMMCC also has a similar agreement with Dewmar International with similar terms. Dewmar's stock has since increased over one thousand percent.

Wendy Haviland, President of Resource Ventures, Inc. said, "The results of this consulting agreement were immediately quantifiable by the fact our stock traded a record 55,000,000 shares. Our stock price increased 800% practically overnight. We are definitely looking forward to the next phase of this new relationship with Hemp, Inc.'s IHMMCC, in which we plan on publicly announcing in the next week or so."

This new wave of activity in the industry prompted Hemp, Inc. to step up its focus on its subsidiary, IHMMCC. Bruce Perlowin, CEO of Hemp, Inc. said, "The Industrial Hemp and Medical Marijuana Consulting Company is the best 'connected' consulting company in the industry, since we were the ones that started the sector and have been there since the very beginning." IHMMCC specializes in helping other public companies move into the medical marijuana, recreational marijuana and industrial hemp industries by finding new products and channels of distribution that fit within these industries.

Perlowin stated, in a past release, "I know where all the gold is hidden in this industry, every nuance of business niche, what will work and won't work, what has been tried before and what new ideas and concepts for the industry will fly or fail. When I'm not sure of something, or it's in one of the many areas outside my particular expertise then I know who to go to, who is an expert in this area and who more likely, than not, will immediately know all the answers or where to find them quickly. Our consulting division is extremely diverse and broad."

"The Industrial Hemp and Medical Marijuana Consulting Company, Inc." pulls industry information from a vast network of specialists that consists of other public industry, public companies' CEOs and networks of experts, bankers, investors, lawyers, other consultants, industry analysts, and non-profits connected to this industry as well as the traditional industry experts in all areas of the various business opportunities the industry presents. Perlowin, and his associates, have an unrivaled wealth of knowledge and experience. This culmination of knowledge and experience has even attracted the attention of banks, which want in on the billions of dollars flowing through the public company sector of this industry.

ABOUT HEMP, INC.

Hemp, Inc. HEMP -7.27% focuses on the vast market created by the quickly emerging, and growing, multibillion dollar industrial hemp industry. Hemp, Inc. HEMP -7.27% is not involved in the cultivation or marketing of medical marijuana. It is the company's belief that legalization of hemp in all 50 states and at the federal level will come to pass. With that in mind, the company is building infrastructure with the potential to gain substantial market share before and after industrial hemp prohibition ends. (Pending any federal licensing or other requirements, that may be enacted after hemp prohibition ends).

ABOUT THE INDUSTRIAL HEMP AND MEDICAL MARIJUANA CONSULTING COMPANY, INC.

The Industrial Hemp and Medical Marijuana Consulting Company (IHMMCC) is a wholly owned subsidiary of Hemp, Inc. HEMP -7.27% that pulls industry information from a vast network of specialists that consists of other public industry, public company CEOs, bankers, investors, lawyers, industry analysts, and non-profits connected to the industry. IHMMCC is entrenched in all the multi-faceted opportunities in the medical marijuana and Industrial Hemp industry. ( www.HempInc.com )

ABOUT RESOURCES VENTURES, INC.

Resources Printing & Graphics is a "Total Graphics" company with its roots in offset printing & direct mail. Our clients count on us for all their graphics needs, including offset printing, direct mail, promotional items, banners & posters, packaging, point of purchase, binders and more. We have served customers nationwide for over 27 years, and now, we have our eyes on international markets. Although based in Southern California and Colorado, our production plants are located across the US and in China.

Resources Printing & Graphics is ready for growth! Our model is simple; customer service is first, with the best quality products available and fast turnarounds. Resources Printing & Graphics is in the early stages of our new online print and graphics website "WikiClickPrint.com". You will simply take your artwork and upload it to the site or use our templates to create your own unique graphics, then place your order and in less than a week you will have your brochures, business cards, stationary or any of the 100+ products we offer. The Company is well positioned for significant future growth.

Hemp, Inc.'s TRIPLE BOTTOM LINE

Hemp, Inc. HEMP -7.27% seeks to benefit many constituencies, not exploit or endanger any group of them. Thus, the publicly-traded company believes in "upstreaming" of a portion of profit from the marketing of their finished hemp goods back to its originator. By Hemp, Inc. focusing on comprehensive investment results--that is, with respect to performance along the interrelated dimensions of people, planet, and profits-- our triple bottom line approach can be an important tool to support sustainability goals.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Hemp, Inc. to be materially different from the statements made herein.

  



 http://www.hempinc.com  
 http://www.herbagenix.com   (hemp-based supplements division)
 http://www.basichemp.com   (hemp protein with enhanced nutritionals)
 http://www.mjlover.com   (MJ Lover for Him; MJ Lover for Her)
 http://www.re-load.biz   (hemp-based nutraceuticals)
 http://www.hempinc.tv   (media and entertainment division)
 http://www.marijuanaincorporated.com  
 http://www.marijuana.tv  
 http://www.cartelblue.com   (eco-friendly clothing)
 http://www.supportpatchadams.com   (hemp gemstone candles and fundraiser for patch adams)



  
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 1

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 12

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 0

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading

Top 5 Most Recently Viewed Articles

Prologis Earnings Report: Investors' Key Insights and Analysis

Updated Category News Views 138

Understanding Prologis's Upcoming Quarterly Earnings Prologis (NYSE: PLD) is set to release its latest quarterly earnings report, and investors are eagerly awaiting the insights it will provide. As the company approaches its earnings announcement, analysts project an earnings per share (EPS) of $1.02, which serves as a benchmark for performance expectations. Investor...

Continue Reading
How Changing U.S. Jobs Report Affects Market Dynamics

Updated Category News Views 171

The recent U. S. employment report sent shockwaves through financial markets, reshaping how traders and investors eyed their portfolios. Stronger-than-expected job creation—with figures soaring over 100,000—meant one thing: the narrative on interest rates was about to change. Gone were the days of comfortably betting on rate cuts; now, everyone’s scrambling to...

Continue Reading
Suno Boosts Innovation for Creators by Acquiring WavTool

Updated Category News Views 157

Suno Boosts Innovation for Creators by Acquiring WavTool Suno has recently made a significant move in the music industry with their acquisition of WavTool. This strategic decision aims to enhance their offerings for songwriters and producers, enabling them to create music that resonates with a broader audience. By integrating WavTool's advanced capabilities into their...

Continue Reading
Leqembi's New IV Treatment Approval: A Milestone for Alzheimer’s Care

Updated Category News Views 274

Leqembi Approved for IV Maintenance Treatment BioArctic AB, a notable player in the biopharmaceutical sector, has made significant headlines with the approval of Leqembi (lecanemab) for intravenous (IV) maintenance treatment for Alzheimer’s disease in the United Kingdom. This groundbreaking decision was announced following rigorous evaluations by the Medicines and...

Continue Reading
Investors of ATYR, MLTX, BAX, and JHX Have Legal Options

Updated Category News Views 145

Overview of Class Action Lawsuits for ATYR, MLTX, BAX, JHX Attention investors! If you’ve invested in aTyr Pharma Inc. (NASDAQ: ATYR), MoonLake Immunotherapeutics (NASDAQ: MLTX), Baxter International, Inc. (NYSE: BAX), or James Hardie Industries plc (NYSE: JHX), it’s important to be aware of significant class action lawsuits affecting your investments. These companies...

Continue Reading